Overview

Behavioral Effects of Drugs: Inpatient (35)

Status:
Completed

Trial end date:
2019-05-31

Target enrollment:

Participant gender:

Summary

This study will determine the influence of methylphenidate (Metadate®) and duloxetine (Cymbalta®), alone and in combination, on the reinforcing, subjective and physiological effects of cocaine.

Phase:

Early Phase 1

Details

Lead Sponsor:

Craig Rush

Collaborator:

National Institute on Drug Abuse (NIDA)

Treatments:

Cocaine
Duloxetine Hydrochloride
Methylphenidate